TRANSCELL Therapeutics, Inc. is a Tennessee corporation formed to develop, manufacture and market a novel class of anti-inflammatory therapeutic agents as pharmaceutical products, based on a proprietary technology researched and developed over the past eight years at Vanderbilt University. Company website is under construction.